BIOSCIENCE

Bioscience

With the largest network of plasma donation centers in the world, the Bioscience Division is a leading producer of plasma-derived medicines for the treatment of rare, chronic and sometimes life-threatening conditions.

To help ensure a reliable, consistent source of plasma medicines worldwide, we have an all-inclusive process that begins with plasma collection and continues through fractionation, purification and production.

Plasma proteins

Immunoglobulins, particularly intravenous immunoglobin (IVIG) in immunology. Used mainly to treat primary immunodeficiencies and chronic inflammatory demyelinating polyneuropathy (CIDP), a rare neurological condition.
Albumin to restore circulating blood volume and protein loss in such physiopathological conditions as liver cirrhosis, trauma, cardio-circulatory insufficiency or severe burns. Research currently underway to assess its potential to treat Alzheimer's.

Alpha-1-antitrypsin to treat alpha-1-antitrypsin deficiency, a rare genetic disease that can lead to severe lung diseases such as emphysema.
Factor VIII and other clotting factors for hematology used primarily to treat hemophilia and other conditions that may result in bleeding episodes, including internal bleeding with subsequent tissue and organ damage.
Other specialty hyperimmune immunoglobulins to treat potentially fatal infections such as rabies, tetanus, hepatitis B and Rh incompatibility.

Plasma quality and product safety

Plasma is the clear, liquid portion of the blood. About 90% is composed of water, while the remaining 10% contains hundreds of essential proteins. Without enough of one of these proteins, a person could have a life-threatening condition.

Donor health and patient safety are our top priorities. We ensure that all plasma donor centers are held to the highest quality and safety standards established by US and European health authorities.

Plasma collection is performed in highly controlled environments by professionally licensed and trained staff. This allows us to maintain very high standards of quality and safety for the medications we produce.

My dad has a genetic form of COPD. Donating plasma helps make the same medications that he uses for his condition. For me, it is personal".

Jacob Del Rio, United States – plasma donor

I donate plasma because I know it helps people who are in need".

Brenda, United States – plasma donor

BIOSCIENCE

From donors to patients

What makes Grifols unique is that people, from donors to patients, are at the heart of everything we do.

Grifols product portfolio

How can we help you?

Pipeline

Take a look at the portfolio of products and therapies currently in development.

Plasma journey

Grifols plasma medicines are a unique class of biologic therapies that require a lengthy and complex manufacturing process.

Diagnostic

Advancing patient care with diagnostic solutions that improve disease detection and management and simplify laboratory operations.

Hospital

Serving the needs of hospital pharmacies to contribute to safe, high-quality healthcare for patients worldwide.

Bio Supplies

Supplying high-quality biological materials for biotechnology research, clinical trials, manufacturing pharmaceutical and diagnostic products.

Content: footer-organization-info

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed to, promoting any products in countries in which they are not approved.

Information for Investors